• Wed, March 13, 2024

Ed Arce Maintained (TVTX) at Strong Buy and Held Target at $17 on, Mar 13th, 2024

Ed Arce of HC Wainwright & Co., Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy and Held Target at $17 on, Mar 13th, 2024.

Ed has made no other calls on TVTX in the last 4 months.



There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 3 agree with Ed's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $9 on, Friday, February 16th, 2024
  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Increased Target to $11 on, Thursday, January 18th, 2024
  • Alex Thompson of "Stifel" Maintained at Hold with Increased Target to $10 on, Monday, December 18th, 2023


These are the ratings of the 2 analyists that currently disagree with Ed


  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $13 on, Friday, February 16th, 2024
  • Carly Kenselaar of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Tuesday, December 5th, 2023